Search the Newsreel

Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories

Bruker Corporation announced an expanded strategic collaboration with Atinary Technologies Inc., a pioneer in Self-Driving Labs technologies and AI-driven R&D, which also includes a minority investment by Bruker. The collaboration aims to integrate Atinary's SDLabs platform with Chemspeed automation and Bruker instruments to create …

Bruker (BRKR) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026 at 9:00 a.m. ET CALL PARTICIPANTS Director of Investor Relations - Joe KostkaPresident and Chief Executive Officer - Frank LaukienExecutive Vice President and Chief Financial Officer - Gerald Herman TAKEAWAYS Revenue -- $838.5 million …

Bruker (BRKR) Could Be 6% Undervalued After Quarterly Loss And 2026 Guidance

Bruker takes majority stake in organ-on-a-chip firm MIMETAS

Bruker Corporation has acquired a majority stake in MIMETAS B.V., a company specializing in organ-on-a-chip platforms and human tissue models for drug discovery. This investment will allow Bruker to integrate MIMETAS' OrganoPlate platform with its existing technologies, expanding its offerings in Microphysiological Systems. MIMETAS …

Bruker Announces Majority Investment in MIMETAS to Advance Human Physiology-Relevant Drug Discovery and Development

Bruker Corporation announced a majority investment in MIMETAS B.V., a developer of organ-on-a-chip platforms and advanced human tissue models. This investment aims to expand Bruker's post-genomic solutions for disease biology research and drug discovery into Microphysiological Systems (MPS). The collaboration will combine MIMETAS's OrganoPlate® …

Why Bruker (BRKR) Is Down 20.3% After Q2 Impairment-Driven Loss And Soft 2026 Guidance

Amundi Increases Stock Position in Bruker Corporation $BRKR

Amundi increased its stake in Bruker Corporation (NASDAQ:BRKR) by 244.2% in the first quarter, now holding 62,611 shares valued at $2.26 million. Despite the company beating EPS estimates for Q2 2026 with $0.49 per share, its revenue of $838.5 million missed analyst expectations, raising …

Bruker Corp (BRKR): FMR LLC and Abigail Johnson report 15% ownership

FMR LLC and Abigail P. Johnson have reported a 15.0% beneficial ownership stake in Bruker Corp (BRKR) common stock, as detailed in a Schedule 13G/A SEC filing. FMR LLC beneficially owns 23,296,465.55 shares, with sole voting power over 17,974,598.38 shares and sole dispositive power …

Bruker Corp (BRKR) Stock Up 4.3% and Still Undervalued -- GF Sco

Bruker Corp (BRKR) shares rose 4.3% to $52.47, trading below its GF Value™ of $62.94, suggesting it is undervalued despite being currently unprofitable and cash-flow negative. The company has a strong GF Score™ of 85/100, driven by good profitability and momentum, though its financial …

Guggenheim Maintains Bruker Corp(BRKR.US) With Buy Rating, Maintains Target Price $70

Guggenheim has reiterated its Buy rating for Bruker Corp (BRKR.US), maintaining a target price of $70. This indicates a continued positive outlook from the firm regarding Bruker's stock performance and value.

Is Bruker (BRKR) Fairly Valued After Its 52 Week High?

Bruker (BRKR) stock has seen significant growth over the past year, reaching a 52-week high, yet analysis suggests it remains undervalued. Discounted Cash Flow (DCF) models indicate the stock trades at approximately a 41.1% discount to its intrinsic value, while its Price/Sales (P/S) multiple …

Bruker: Q2 Earnings Snapshot

Bruker Corp. reported a second-quarter loss of $52 million, or 41 cents per share, which was a reversal from a profit in the same period last year. Despite the loss, adjusted earnings of 49 cents per share surpassed Wall Street expectations. The scientific equipment …

Bruker (BRKR) Is Down 20.0% After Goodwill Impairment-Fueled Q2 Loss Despite Higher Sales

Bruker Corporation's Q2 2026 results, released on August 4, 2026, showed sales rising to US$838.5 million from US$797.4 million year over year, but a goodwill and intangible asset impairment charge of US$134.9 million and other items drove a net loss of US$52 million versus …

Bruker Corporation (NASDAQ: BRKR) hit by $134.9M goodwill charge in Q2

Bruker (NASDAQ:BRKR) Posts Quarterly Earnings Results, Beats Estimates By $0.11 EPS

Bruker (BRKR) came out with quarterly earnings of $0.49 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.32 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings …

Bruker (BRKR) Could Be 16% Below Fair Value On Q2 Results And 2026 Guidance

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Bruker (BRKR) just updated its 2026 revenue guidance alongside second quarter results, pairing a …

Bruker Q2 2026 slides: margins surge but revenue miss triggers selloff

Bruker Corporation (NASDAQ:BRKR) reported Q2 2026 earnings with a significant surge in non-GAAP earnings per share and strong margin expansion, but a revenue miss against Wall Street expectations triggered an 18.13% stock selloff. Despite operational improvements and growth in key segments like semiconductor metrology, …

Bruker Corporation Q2 2026 Earnings Call Summary

Bruker Corporation reported a pivot back to organic revenue growth in Q2 2026, driven by strong demand in "deep tech" sectors like semiconductor metrology and energy research, despite softness in the U.S. academic and government sectors. The company implemented a new four-group operating structure …

Bruker Corporation (BRKR) carries a 42.4% 12-week advance into earnings

The Aug. 4 report will test whether an active weekly trend can offset softer relative-strength and below-average volume readings.

Bruker Reports Second-Quarter 2026 Results as Scientific Instruments Bookings Accelerate

Researcher looking through microscope ©Adobe Stock Images Bruker (NASDAQ:BRKR) returned to organic revenue growth in the second quarter, posted stronger bookings across its Scientific Instruments business, and maintained its earnings outlook while adjusting guidance for currency and tax changes. Key Investor Takeaways Bruker (NASDAQ:BRKR) …

Earnings call transcript: Bruker beats Q2 EPS forecast but shares sink on revenue miss, Q2 2026

Bruker Corp. reported mixed results for Q2 2026, beating EPS forecasts at $0.49 but missing revenue estimates at $838.5 million. Stronger margins and cost reductions, partially due to tariff refunds, bolstered profits, but lower-than-expected sales growth and a cautious near-term outlook led to a …

Bruker (BRKR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Bruker (BRKR) reported its Q2 2026 earnings, with revenues of $838.5 million, up 5.2% year-over-year, and EPS of $0.49, significantly higher than $0.32 in the prior year quarter. The company surpassed EPS estimates by 28.95% but missed revenue estimates by 2.18%. Key metrics like …

BRUKER ($BRKR) Releases Q2 2026 Earnings

Bruker Corporation (Nasdaq: BRKR) posts $838.5M sales, EPS loss

Bruker Corporation reported Q2 2026 revenue of $838.5 million, a 5.2% year-over-year increase, but posted a GAAP diluted loss per share of $(0.41) due to a significant non-cash goodwill impairment charge of $134.9 million. Despite the GAAP loss, the company achieved positive non-GAAP diluted …

Bruker Reports Q2 2026 Revenue $838.5M; Non-GAAP EPS $0.49, Updates FY26 Guidance

Bruker reported its second-quarter 2026 results, with revenues of $838.5 million and non-GAAP diluted EPS of $0.49, despite a GAAP diluted loss per share of $(0.41) due to a non-cash goodwill impairment. The company also updated its full-year 2026 guidance for currency and tax, …

Bruker Corporation 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:BRKR) 2026-08-04

Bruker Corporation reported a pivot back to organic revenue growth in Q2 2026, driven by strong demand in "deep tech" sectors like semiconductor metrology and energy research, despite softness in the U.S. academic and government sectors. The company implemented a new four-group operating structure …

Bruker (NASDAQ:BRKR) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings, Stock Drops 11.9%

Bruker (NASDAQ:BRKR) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings, Stock Drops 11.9% Scientific instrument company Bruker (NASDAQ:BRKR) missed Wall Street's revenue expectations in Q2 CY2026, but sales rose 5.2% year on year to $838.5 million. The company's full-year revenue guidance of $3.56 …

Bruker (BRKR) Stock Price Sinks After Goodwill Hit Triggers Loss

BRKR Q2 Deep Dive: Margin Expansion and Delayed Revenue Impact Market Sentiment

Bruker Q2 2026 Earnings: Margin Expansion Was Masked by a Goodwill Impairment

Earnings To Watch: Bruker (BRKR) Reports Q2 Results Tomorrow

Bruker Corporation stock hits 52-week high at 65.3 USD

Bruker Corporation (BRKR) stock reached a 52-week high of $65.3 USD, reflecting a significant 71.89% increase over the last 12 months. The company's performance is boosted by strategic acquisitions and strong demand in the semiconductor sector, leading analysts to reiterate "Buy" and "Outperform" ratings …

Bruker Corp (BRKR) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Bruker Corp (BRKR), detailing its current valuation score, P/E ratio, and ranking within the Healthcare Equipment & Supplies industry. It highlights that the company's P/E ratio is -268.08, significantly below its recent high and above its recent …